KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 90 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 1.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,234,791 | +13.7% | 1,176,710 | +93.9% | 0.03% | -5.9% |
| Q2 2023 | $1,086,011 | -53.0% | 606,710 | +2.2% | 0.03% | -52.1% |
| Q1 2023 | $2,309,901 | -99.8% | 593,805 | +118.9% | 0.07% | +153.6% |
| Q3 2022 | $1,481,000,000 | +44.3% | 271,219 | +19.2% | 0.03% | +86.7% |
| Q2 2022 | $1,026,000,000 | +224.7% | 227,599 | +658.7% | 0.02% | +150.0% |
| Q3 2015 | $316,000,000 | -58.7% | 30,000 | +20.0% | 0.01% | -62.5% |
| Q1 2015 | $765,000,000 | – | 25,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |